* Bio Path Holdings Inc BPTH.OQ BPTH.O is expected
to show no
change in quarterly revenue when it reports results on August
15 for the period ending June 30 2024
*
* LSEG's mean analyst estimate for Bio Path Holdings Inc is
for a
loss of $1.54 per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Bio Path
Holdings
Inc is $20.00, above its last closing price of $1.31.
This summary was machine generated August 13 at 14:27 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)